Skip to main content


Crizalk 250mg contains the active substance Crizotinib. It is an antineoplastic medicine that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic. #mrmed #mrmedpharmacy #alkpositive #lungcancer #nsclc #crizalkcapsule Know more: https://www.mrmed.in/medicines/crizalk-250mg-capsule